IT8220274A0 - Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica. - Google Patents
Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica.Info
- Publication number
- IT8220274A0 IT8220274A0 IT8220274A IT2027482A IT8220274A0 IT 8220274 A0 IT8220274 A0 IT 8220274A0 IT 8220274 A IT8220274 A IT 8220274A IT 2027482 A IT2027482 A IT 2027482A IT 8220274 A0 IT8220274 A0 IT 8220274A0
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical formulations
- topical administration
- formulations containing
- new pharmaceutical
- containing coenzyme
- Prior art date
Links
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000011200 topical administration Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT20274/82A IT1157269B (it) | 1982-03-19 | 1982-03-19 | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
FR8304506A FR2523443B1 (fr) | 1982-03-19 | 1983-03-18 | Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique |
BE0/210350A BE896205A (fr) | 1982-03-19 | 1983-03-18 | Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique |
DE19833309850 DE3309850A1 (de) | 1982-03-19 | 1983-03-18 | Neue pharmazeutische coenzym q(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)0(pfeil abwaerts) enthaltende zubereitungen |
JP58046988A JPS58222016A (ja) | 1982-03-19 | 1983-03-19 | 局所投与に適する補酵素q↓1↓0を含有する医薬組成物とその製剤法 |
GB08307759A GB2116426B (en) | 1982-03-19 | 1983-03-21 | New pharmaceutical formulations containing coenzyme q10 |
US06/711,034 US4654373A (en) | 1982-03-19 | 1985-03-12 | Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT20274/82A IT1157269B (it) | 1982-03-19 | 1982-03-19 | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8220274A0 true IT8220274A0 (it) | 1982-03-19 |
IT1157269B IT1157269B (it) | 1987-02-11 |
Family
ID=11165341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT20274/82A IT1157269B (it) | 1982-03-19 | 1982-03-19 | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
Country Status (7)
Country | Link |
---|---|
US (1) | US4654373A (it) |
JP (1) | JPS58222016A (it) |
BE (1) | BE896205A (it) |
DE (1) | DE3309850A1 (it) |
FR (1) | FR2523443B1 (it) |
GB (1) | GB2116426B (it) |
IT (1) | IT1157269B (it) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1157269B (it) * | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
JPS5913710A (ja) * | 1982-07-15 | 1984-01-24 | Shiseido Co Ltd | 養毛料 |
JPS60100517A (ja) * | 1983-11-08 | 1985-06-04 | Eisai Co Ltd | 放射線潰瘍治療剤および方法 |
JPS61210028A (ja) * | 1985-03-15 | 1986-09-18 | Eisai Co Ltd | 褥瘡治療剤 |
CH662505A5 (it) * | 1985-04-30 | 1987-10-15 | Seuref Ag | Composizioni farmaceutiche ad azione protettiva vascolare. |
JPS61289029A (ja) * | 1985-06-11 | 1986-12-19 | Shiseido Co Ltd | 抗色素沈着剤 |
JPS6339813A (ja) * | 1986-08-05 | 1988-02-20 | Eisai Co Ltd | 創傷治療剤 |
US4929437A (en) * | 1989-02-02 | 1990-05-29 | Merck & Co., Inc. | Coenzyme Q10 with HMG-CoA reductase inhibitors |
US5378461A (en) * | 1991-07-12 | 1995-01-03 | Neigut; Stanley J. | Composition for the topical treatment of skin damage |
US6461593B1 (en) * | 1992-02-19 | 2002-10-08 | Biomedical And Clinical Research | Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
US6255354B1 (en) * | 1997-02-12 | 2001-07-03 | Mse Pharmazeutika Gmbh | Preparation of a pulmonary surfactant for instillation and oral application |
EP1007018B1 (de) * | 1997-02-12 | 2003-10-08 | MSE Pharmazeutika GmbH | Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon inder behandlung von tinnitus |
US6207137B1 (en) | 1997-06-12 | 2001-03-27 | C.S. Bioscience, Inc. | Dental formulation |
US6503483B2 (en) * | 1997-06-12 | 2003-01-07 | C.S. Bioscience, Inc. | Dental formulation |
US5908613A (en) * | 1997-09-08 | 1999-06-01 | Bozzacco; Craig | Composition for the treatment and prevention of periodontal disease |
DE19806947A1 (de) * | 1998-02-19 | 1999-08-26 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen |
US6048886A (en) * | 1998-10-05 | 2000-04-11 | Neigut; Stanley | Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin |
US6200550B1 (en) | 1998-12-11 | 2001-03-13 | Q-Pharma, Inc. | Oral care compositions comprising coenzyme Q10 |
US6106286A (en) * | 1999-01-22 | 2000-08-22 | Gupta; Subhash | Method and device for administering medicine to the periodontium |
DE19944137A1 (de) * | 1999-09-15 | 2001-03-22 | Beiersdorf Ag | O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin |
CA2406570C (en) * | 2000-05-09 | 2011-07-12 | Kaneka Corporation | Dermal compositions containing coenzyme q as the active ingredient |
DE10036798A1 (de) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | Mittel zur Behandlung der Haare und der Kopfhaut |
US6372198B1 (en) * | 2000-09-14 | 2002-04-16 | Joseph M. Abbate | Dentifrice for the mineralization and remineralization of teeth |
KR100612398B1 (ko) * | 2000-11-14 | 2006-08-16 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 포스페이트 유도체의 착체 |
AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
US6864231B2 (en) * | 2001-01-09 | 2005-03-08 | Pharmachem Laboratories, Inc. | Glycoprotein matrix compositions and methods related thereto |
US6806069B2 (en) * | 2001-01-09 | 2004-10-19 | Pharmachem Laboratories, Inc. | Ubiquinone composition and methods related thereto |
DE10111053A1 (de) * | 2001-03-06 | 2002-09-12 | Beiersdorf Ag | Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen |
US20030031688A1 (en) * | 2001-04-02 | 2003-02-13 | Dipak Ghosh | Cosmetic composition with improved skin moisturizing properties |
CN1547475B (zh) | 2001-07-27 | 2010-12-15 | 生命健康科学有限公司 | 含电子转移试剂的磷酸酯衍生物的皮肤制剂 |
DE10139851A1 (de) * | 2001-08-14 | 2003-03-13 | Beiersdorf Ag | Hautpflegeprodukte mit einer Kombination aus Biotin, Ubichinonen und Cyclodextrinen |
DE10146802A1 (de) * | 2001-09-22 | 2003-04-24 | Beiersdorf Ag | Vitaminhaltige Hautpflegeprodukte |
TWI329513B (en) * | 2001-10-12 | 2010-09-01 | Kaneka Corp | Use of reduced coenzyme q for lessening oxidative stress |
WO2003049774A1 (en) * | 2001-12-13 | 2003-06-19 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
US7544674B2 (en) | 2002-10-25 | 2009-06-09 | Galderma S.A. | Topical skin care composition |
MXPA05007278A (es) * | 2003-01-17 | 2005-09-30 | Vital Health Sciences Pty Ltd | Compuestos que tienen propiedades anti-proliferativas. |
AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
US7169401B2 (en) * | 2003-07-18 | 2007-01-30 | Hill Dermaceuticals, Inc. | Topical skin care composition containing refined peanut oil |
US20070140999A1 (en) * | 2003-07-18 | 2007-06-21 | Hill Dermaceuticals, Inc. | Topical skin care composition containing refined peanut oil |
US20060099173A1 (en) * | 2003-10-24 | 2006-05-11 | Nancy Puglia | Topical skin care composition |
MXPA06008293A (es) * | 2004-01-22 | 2007-06-11 | Univ Miami | Formulaciones topicas de coenzima q10 y metodos de uso. |
JP4847437B2 (ja) * | 2004-03-03 | 2011-12-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | アルカロイド製剤 |
DE102004032837A1 (de) | 2004-07-02 | 2006-02-09 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen |
JP2008531602A (ja) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗癌特性を有する化合物 |
JP2006248940A (ja) * | 2005-03-09 | 2006-09-21 | Eikodo Honten:Kk | 皮膚若しくは毛髪用化粧料 |
ES2557475T3 (es) * | 2005-06-17 | 2016-01-26 | Vital Health Sciences Pty Ltd. | Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones |
KR20080085839A (ko) * | 2005-12-23 | 2008-09-24 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 사이토킨 조절 특성을 가진 화합물 |
US20070237735A1 (en) * | 2006-03-31 | 2007-10-11 | Laboratoires Dermo-Cosmetik Inc. | Anti-aging composition, kit and method of use |
ES2755840T3 (es) | 2007-03-22 | 2020-04-23 | Berg Llc | Formulaciones tópicas que tienen biodisponibilidad aumentada |
WO2009126764A1 (en) | 2008-04-11 | 2009-10-15 | Cytotech Labs, Llc | Methods and use of inducing apoptosis in cancer cells |
CN102482713B (zh) * | 2009-05-11 | 2017-06-30 | 博格有限责任公司 | 利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法 |
DE102009027024A1 (de) | 2009-06-18 | 2010-12-23 | Henkel Ag & Co. Kgaa | Antifalten-Kosmetikum mit Antioxidantien |
WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
EP3366280A1 (en) * | 2010-03-12 | 2018-08-29 | Berg LLC | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
EP2552486B1 (en) | 2010-03-30 | 2020-08-12 | Phosphagenics Limited | Transdermal delivery patch |
DE102010050570A1 (de) * | 2010-11-05 | 2012-05-10 | F. Holzer Gmbh | Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
JP6092844B2 (ja) | 2011-04-04 | 2017-03-08 | バーグ エルエルシー | 中枢神経系腫瘍の治療方法 |
JP5932993B2 (ja) | 2011-06-17 | 2016-06-08 | バーグ エルエルシー | 吸入可能な医薬組成物 |
AU2014251045B2 (en) | 2013-04-08 | 2019-06-13 | Berg Llc | Treatment of cancer using coenzyme Q10 combination therapies |
MX2016002873A (es) | 2013-09-04 | 2016-06-22 | Berg Llc | Metodos de tratamiento de cancer por infusion continua de coenzima q10. |
ES2702320T3 (es) | 2014-05-06 | 2019-02-28 | Beiersdorf Ag | Formas de dosificación cosméticas en forma de perla |
DE202014003724U1 (de) | 2014-05-06 | 2014-05-14 | Beiersdorf Ag | Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations-und/oder UV-empfindliche Wirkstoffe enthält |
DE202014003722U1 (de) | 2014-05-06 | 2014-06-05 | Beiersdorf Ag | Perlenförmige kosmetische Darreichungsformen |
EP2942047B1 (de) | 2014-05-06 | 2020-09-02 | Beiersdorf AG | Kosmetisches Produkt |
DE102014208436B4 (de) | 2014-05-06 | 2016-02-25 | Beiersdorf Ag | Perlenförmige kosmetische Darreichungsformen |
DE102014208441A1 (de) | 2014-05-06 | 2015-11-12 | Beiersdorf Ag | Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations- und/oder UV-empfindliche Wirkstoffe enthält |
DE202014003725U1 (de) | 2014-05-06 | 2014-05-14 | Beiersdorf Ag | Kosmetisches Produkt |
DE102014208440B4 (de) | 2014-05-06 | 2018-09-27 | Beiersdorf Ag | Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations- und/oder UV-empfindliche Wirkstoffe enthält |
DE102014208450B4 (de) | 2014-05-06 | 2017-04-06 | Beiersdorf Ag | Kosmetisches Produkt |
DE102014208438A1 (de) | 2014-05-06 | 2015-11-12 | Beiersdorf Ag | Perlenförmige kosmetische Darreichungsformen |
PL2942046T3 (pl) | 2014-05-06 | 2019-04-30 | Beiersdorf Ag | Preparaty z zewnętrzną fazą żelową i wewnętrzną fazą cząsteczkową,która zawiera ustabilizowane substancje wrażliwe na utlenianie i/lub promieniowanie uv |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
DE102016225095A1 (de) | 2016-12-15 | 2018-06-21 | Henkel Ag & Co. Kgaa | "Kosmetische Gesichtspflegeformulierungen zur Stimulierung der körpereigenen Abwehr gegen freie Radikale" |
CA3045702A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Phosphorylation process of complex alcohols |
DE102018210184A1 (de) | 2018-06-22 | 2019-12-24 | Beiersdorf Ag | Kosmetisches Produkt, umfassend kosmetisches oder dermatologisches Produkt, enthaltend sichtbare, in einem transparenten, flüssigen oder gelförmigen Träger suspendierte Perlen, wobei die Perlen einen unangenehmen Eigengeruch entwickelnden kosmetischen oder dermatologischen Wirkstoff verkapseln |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1317865A (en) * | 1971-11-15 | 1973-05-23 | Jujo Paper Co Ltd | Biologically active composition |
JPS5299223A (en) * | 1976-02-14 | 1977-08-19 | Eisai Co Ltd | Medicines for alopecia areata |
JPS5938202B2 (ja) * | 1976-03-05 | 1984-09-14 | エーザイ株式会社 | 難聴治療剤 |
JPS5489036A (en) * | 1977-12-27 | 1979-07-14 | Eisai Co Ltd | Remedy and preventive for hypersensitivity to light |
JPS5618914A (en) * | 1979-07-25 | 1981-02-23 | Eisai Co Ltd | Ubidecarenone composition having good absorbability |
FR2472384A1 (fr) * | 1979-12-27 | 1981-07-03 | Sederma Sa | Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides |
JPS58113127A (ja) * | 1981-12-28 | 1983-07-05 | Ajinomoto Co Inc | ユビデカレノン含有水性液 |
IT1157269B (it) * | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
-
1982
- 1982-03-19 IT IT20274/82A patent/IT1157269B/it active
-
1983
- 1983-03-18 BE BE0/210350A patent/BE896205A/fr not_active IP Right Cessation
- 1983-03-18 DE DE19833309850 patent/DE3309850A1/de not_active Ceased
- 1983-03-18 FR FR8304506A patent/FR2523443B1/fr not_active Expired
- 1983-03-19 JP JP58046988A patent/JPS58222016A/ja active Pending
- 1983-03-21 GB GB08307759A patent/GB2116426B/en not_active Expired
-
1985
- 1985-03-12 US US06/711,034 patent/US4654373A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3309850A1 (de) | 1983-09-29 |
BE896205A (fr) | 1983-07-18 |
IT1157269B (it) | 1987-02-11 |
JPS58222016A (ja) | 1983-12-23 |
GB8307759D0 (en) | 1983-04-27 |
FR2523443A1 (fr) | 1983-09-23 |
GB2116426A (en) | 1983-09-28 |
GB2116426B (en) | 1985-09-25 |
US4654373A (en) | 1987-03-31 |
FR2523443B1 (fr) | 1986-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8220274A0 (it) | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica. | |
MX9203263A (es) | Composicion farmaceutica analgesica para administracion nasal. | |
DE3169761D1 (en) | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them | |
DE2965284D1 (en) | Pharmaceutical compositions for topical administration containing prostaglandins | |
AU587787B2 (en) | Osmotic system for delivering drug to colon | |
DK163959C (da) | Farmaceutisk praeparat til oral indgift indeholdende cimetidin | |
IT8619625A0 (it) | Composizioni farmaceutiche per inalazione. | |
IL63036A (en) | Dosage units for oral administration | |
AU4888685A (en) | Osmotic system for delivering drug to the colon | |
FI830678L (fi) | Bio-laempliga jaernderivat, som inte foerorsakar magsaor, framstaellningsfoerfarande och till sakenhoerande farmaceutiska foereningar | |
FI822670A0 (fi) | Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling | |
IL68456A (en) | Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles | |
GB2184355B (en) | Ubiquinone pharmaceutical compositions | |
NZ196288A (en) | Pharmaceutical active substance administration | |
IL79236A0 (en) | Pharmaceutical compositions containing vitamin d derivatives | |
IT8722501A0 (it) | Formulazioni farmaceutiche per somministrazione transdermica. | |
IT8521945A0 (it) | 2-piridilcarbossammide particolarmente per uso farmaceutico. | |
GB2052980B (en) | Pharmaceutical composition for oral administration comprising methoxsalen | |
DE2860796D1 (en) | Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them | |
IT8119824A0 (it) | Prodotto medicinale per uso topico contenente indometacina. | |
IT8722647A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
IT8219012A0 (it) | Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche. | |
IT8521214A0 (it) | Composizione farmaceutica solida per uso orale. | |
IT8349055A0 (it) | B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico | |
NL194231B (nl) | Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970326 |